8-KThe WireStrategic
Security-Holder Rights · Bylaw Amendment
Filed Mar 28, 2024 · 2y ago · Accession 0001104659-24-040608
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- 8-K
- Filing date
- Mar 28, 2024
- Report date
- Mar 28, 2024
- Document
- tm2410082d1_8k.htm
- Size
- 284 KB